Brain Metastases v1.0.0 and Adaptive Hybrid Surgery Analysis (AHSA) v1.0.0(Used for Linac based radiation treatment planning of cranial, head and neck, and extracranial lesions) 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Brainlab Australia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2016-RN-00046-2
  • 사례 위험등급
    Class I
  • 사례 시작날짜
    2016-01-15
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Brainlab image fusion is used for co-registration of medical images. when loading the fusion result in affected devices, under specific circumstances, the fusion result stored by image fusion is disregarded. instead the image datasets are co-registered based on the scanner-inherent fusion that can potentially result from acquiring the images in one imaging session. in consequence, the image datasets may become shifted e.G. organs at risk or planning target volume, may become shifted in relation to their anatomical position. while using brain metastases 1.0.0, if the shifted objects are not recognised by the user before the plan is used for treatment and the deviation exceeds clinically acceptable limits, this could result in ineffective radiation treatment. while using ahsa 1.0.0, the incorrect information displayed can have an effect on clinical decisions. in a worst case scenario, this can mislead the clinician in assessing the extent of tumour resection during surgery.
  • 조치
    Brainlab will implement a software update for the affected systems. In the interim, users of affected systems are advised to adhere to the following: If possible do not use image datasets with an identical coordinate system (i.e. same frame of reference information), unless the scanner fusion is acceptable to be approved in Image Fusion. Always carefully review and verify the fusion result and all objects for correctness and validity in Brain Metastases or Adaptive Hybrid Surgery Analysis. Specifically if the error message is displayed by the software, review the position of all objects in the CT used for treatment planning and in the image datasets with the same frame of reference. Please note that the error will not be visible in SmartBrush, Image Fusion and DICOM Viewer. Always verify the fusion result and correct position of objects in Brain Metastases or Adaptive Hybrid Surgery Analysis.

Device

  • 모델명 / 제조번호(시리얼번호)
    Brain Metastases v1.0.0 and Adaptive Hybrid Surgery Analysis (AHSA) v1.0.0(Used for Linac based radiation treatment planning of cranial, head and neck, and extracranial lesions)ARTG Number: 230067
  • Manufacturer

Manufacturer